| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |